All Stories

  1. Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats
  2. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis
  3. A biochemical & biophysical study on in-vitro anti-glycating potential of iridin against d-Ribose modified BSA
  4. Modulatory role of HMG-CoA reductase inhibitors and ezetimibe on LDL-AGEs-induced ROS generation and RAGE-associated signalling in HEK-293 Cells
  5. Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in rats
  6. Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality
  7. Glycation and HMG-CoA Reductase Inhibitors: Implication in Diabetes and Associated Complications
  8. Functioning of Organosulfur Compounds from Garlic (Allium sativum Linn) in Targeting Risk Factor-Mediated Atherosclerosis: A Cross Talk Between Alternative and Modern Medicine
  9. Secondary Metabolites from Rosemary (Rosmarinus officinalis L.): Structure, Biochemistry and Therapeutic Implications Against Neurodegenerative Diseases
  10. Antiglycation study of HMG-R inhibitors and tocotrienol against glycated BSA and LDL: A comparative study
  11. Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity
  12. Potential role of lycopene in targeting proprotein convertase subtilisin/kexin type-9 to combat hypercholesterolemia
  13. Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor:in vitroandin silicostudy